Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Dentsply Sirona
XRAY
$2.31B
| $4.69M | ﹤0.01% |
89,525
-193,602
| -68% | -$9.55M |
|
3677
Omega Healthcare
OHI
$14.1B
| $4.68M | ﹤0.01% |
128,988
-586,940
| -82% | -$19.9M |
|
3678
Virgin Galactic
SPCE
$503M
| $4.68M | ﹤0.01% |
9,869
+5,298
| +116% | +$2.47M |
|
3679
WisdomTree International Quality Dividend Growth Fund
IQDG
$732M
| $4.68M | ﹤0.01% |
+128,279
| New | +$4.39M |
|
3680
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $4.68M | ﹤0.01% |
+92,182
| New | +$4.68M |
|
3681
HealthEquity
HQY
$8.76B
| $4.68M | ﹤0.01% |
67,150
-541,756
| -89% | -$33.7M |
|
3682
PUT
Alerian MLP ETF
AMLP
$13.2B
| $4.68M | ﹤0.01% |
182,300
+86,400
| +90% | +$2.08M |
|
3683
TC Energy
TRP
$66.7B
| $4.68M | ﹤0.01% |
114,889
-222,367
| -66% | -$9.47M |
|
3684
PUT
CryoPort
CYRX
$772M
| $4.67M | ﹤0.01% |
106,500
+6,000
| +6% | +$286K |
|
3685
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $4.67M | ﹤0.01% |
112,000
-87,000
| -44% | -$3.39M |
|
3686
Kemper
KMPR
$1.62B
| $4.67M | ﹤0.01% |
60,744
+39,757
| +189% | +$2.83M |
|
|
SA
3687
CALL
Seabridge Gold
SA
$3.62B
| $4.66M | ﹤0.01% |
221,300
+40,000
| +22% | +$774K |
|
3688
PUT
Hartford Financial Services
HIG
$37.8B
| $4.66M | ﹤0.01% |
95,100
-36,900
| -28% | -$1.59M |
|
|
KNDI
3689
PUT
Kandi Technologies Group
KNDI
$63M
| $4.66M | ﹤0.01% |
674,800
+606,400
| +887% | +$4.99M |
|
3690
Nucor
NUE
$61B
| $4.64M | ﹤0.01% |
87,271
-33,382
| -28% | -$1.72M |
|
|
DRE
3691
DELISTED
Duke Realty Corp.
DRE
| $4.64M | ﹤0.01% |
116,058
+75,204
| +184% | +$2.93M |
|
|
3692
CALL
HealthEquity
HQY
$8.76B
| $4.64M | ﹤0.01% |
66,500
+20,400
| +44% | +$1.27M |
|
3693
CALL
Globant
GLOB
$1.61B
| $4.63M | ﹤0.01% |
21,300
-18,900
| -47% | -$3.65M |
|
3694
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
| $4.63M | ﹤0.01% |
+83,646
| New | +$4.59M |
|
3695
PUT
Vistra
VST
$49.7B
| $4.63M | ﹤0.01% |
235,300
+39,700
| +20% | +$739K |
|
3696
CALL
3D Systems Corp
DDD
$616M
| $4.62M | ﹤0.01% |
441,200
+277,700
| +170% | +$2.26M |
|
|
TMPMU
3697
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
| $4.62M | ﹤0.01% |
+450,000
| New | +$4.56M |
|
3698
Take-Two Interactive
TTWO
$46.2B
| $4.62M | ﹤0.01% |
22,229
-7,964
| -26% | -$1.39M |
|
3699
CALL
Progyny
PGNY
$2.02B
| $4.62M | ﹤0.01% |
108,900
+12,200
| +13% | +$397K |
|
3700
PVH
PVH
$3.8B
| $4.61M | ﹤0.01% |
49,074
+44,047
| +876% | +$3.35M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.